Good MorningThe rebound in equities paused on Tuesday as traders brace for what could be a difficult few days. The upcoming CPI and PPI reports should confirm peak interest rates but may not point to the first interest rate cuts. In that scenario, the FOMC may not make the first interest rate cuts until late in the year or later, after last year's hikes have had time to fully impact the economy. Until then, the risk of recession remains.
The CME FedWatch Tool indicates a better-than-60% chance for a rate cut at the next FOMC meeting in less than a month. A warmer-than-expected inflation reading would blow that outlook out of the water and may send the S&P 500 crashing. As it is, the broad market index is trading beneath critical resistance at the all-time high, and the action looks toppy with earnings season set to begin on Friday. Featured: Sell these "safe" blue chips immediately (Ad) 
|
Healthcare | |
Up 2% five trading days into the new year, global health care stocks have already matched their return for all of 2023. It’s very early, but the sector has outpaced all other 10 economic groups since the ball dropped in Times Square. Following a year that was dominated by technology, could 2... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Industrials | |
The airline industry was devastated by the COVID-19 pandemic. Travel and leisure became an epicenter industry as lockdowns and travel restrictions limited the availability of flights, crews and even pilots. Airline stocks plummeted.
Debt levels climbed as investors wondered if the industry would... Read the Full Story |
|
Technology | |
While it was one of the first stocks to reclaim an all-time high last year, Apple Inc (NASDAQ: AAPL) has found itself lagging the broader market in recent weeks. The divergence is rare and noteworthy as a result. To be sure, Apple stock experiences its fair share of down days, but these are usuall... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Industrials | |
With the FOMC on track to cut rates in the back half of the year and the average 30-year rate already below 7.5%, the building market will stabilize and return to growth, which is good news for names like Acuity Brands, Inc. (NYSE: AYI). Acuity Brands has business in all construction industry segm... Read the Full Story |
|
Consumer Discretionary | |
Whether it be a pair of jeans, a smart TV or a box of cereal, ‘25% off’ is a significant deal these days. In the U.S. stock market, mid-cap stocks are that deal.
Based on Wall Street’s earnings per share (EPS) estimates for the next 12 months, the mid-cap S&P 400 index is tr... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Industrials | |
The discouraging start to 2024 didn’t result in the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) falling anywhere close to its 50-day moving average.
A rally of 1.43% on January 8 brought the broad index back above its 5-day and 10-day lines, as American Airlines Group Inc. (NASDAQ: AAL), Ar... Read the Full Story |
|
Healthcare | |
Hot stocks come in two forms: those that are hot to buy and those that are hot to sell. Today, we’re looking at four midcap stocks the insiders are buying and whether or not the stocks are good for investors. It is certain that insider buying is a good thing and points to solid business and ... Read the Full Story |
|
Consumer Discretionary | |
Advanced driver assistance systems (ADAS) and autonomous driving technology provider Mobileye Global Inc. (NASDAQ: MBLY) shocked investors when it unexpectedly cut its fiscal 2024 guidance on Jan. 4, 2024. Shares collapsed 24% in reaction. The gloomy outlook stemmed from an inventory glut arising ... Read the Full Story |
|
Energy | |
Barron's helped thousands beat the market by roughly 6.5% with their top stock picks for 2023. Could history repeat itself? If you are at the desk wondering which stocks deserve to get a taste of your investment dollars this year, here's why you should consider Chevron (NYSE: CVX) as one of Barron... Read the Full Story |
|
Communication Services | |
Pop-up ads, auto-play videos, tracking cookies and getting inundated with in-your-face promotions helped give rise to alternative web browsers like Opera Inc. (NASDAQ: OPRA) with built-in ad-blocking and private VPN technology in the computer and technology sector.
Social media sites can be just... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois. | | View Today's Stock Pick |
|
